First published 10/3/2026, 7:30:15 PM · Last updated 10/3/2026, 7:30:15 PM

Suppressive effects of lotus plumule (Nelumbo nucifera Geartn.) supplementation on LPS-induced systemic inflammation in a BALB/c mouse model

A journal article published by the Journal of Food and Drug Analysis reports that lotus plumule (Nelumbo nucifera) supplementation suppressed LPS-induced systemic inflammation in a BALB/c mouse model. Publisher information credits the Food and Drug Administration, Taiwan (TFDA).

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article documents an experimental intervention that reduced experimentally induced systemic inflammation in a mouse model.

Sources

Suppressive effects of lotus plumule (Nelumbo nucifera Geartn.) supplementation on LPS-induced systemic inflammation in a BALB/c mouse modelMetadata provided by Crossref. Usage terms

Report an issue